临床试验

Pharmacologic Augmentation of TMS for Depression With D-serine

NCT：NCT06876129 · RECRUITING

NCT编号NCT06876129

状态RECRUITING

开始日期2025-04-01

完成时间2027-04-01

SponsorMclean Hospital (OTHER)

First posted2025-03-14

Last updated2026-05-15

简要摘要

The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce greater clinical outcomes than iTBS with placebo and 18-Hz with placebo.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。